Ticker League

Bristol-Myers Squibb (BMY) Profit Bridge

See what drove Bristol-Myers Squibb's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

Revenue YoY

+1.78%

Operating Income YoY

+13.93%

Net Income YoY

+34.20%

Net Margin Δ

+362 bps

Net income bridge for Bristol-Myers Squibb (BMY) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: $1.86B+34.20%

Profit bridge breakdown for Bristol-Myers Squibb (BMY) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income$5.42B
  • Revenue$846.00M
  • Cost of Revenue$4.30B
  • Operating Expenses−$3.63B
  • Other Income / Expense$1.97B
  • Income Tax−$1.65B
  • Other Items$20.00M
  • Net Income$7.28B
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology